Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received February 28, 2022
- Revision received March 14, 2022
- Accepted March 15, 2022
- Published online April 30, 2022.
Copyright & Usage
Copyright © 2022 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Author Information
- 1Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University College of Medicine, Seoul, Republic of Korea;
- 2Division of Biostatistics, Department of R&D Management, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea;
- 3Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
- Correspondence to: Hyun-Soo Kim, Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81, Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea. Tel: +82 234101243, Fax: +82 234142831, e-mail: hyun-soo.kim{at}samsung.com; Sung-Im Do, Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine 29, Saemunan-ro, Jongno-gu, Seoul 03181, Republic of Korea. Tel: +82 220012389, Fax: +82 220012398, e-mail: sungim.do{at}samsung.com
In this issue
High Receptor-interacting Serine/Threonine-protein Kinase 3 (RIP3) Expression Serves as an Independent Poor Prognostic Factor for Triple-negative Breast Carcinoma
Jump to section
Related Articles
Cited By...
- No citing articles found.